Survival of motor neuron protein over-expression prevents calpain-mediated cleavage and activation of procaspase-3 in differentiated human SH-SY5Y cells

Neuroscience

Volumn 181, Issue , 2011, Pages 226-233

  Anderton, R S ^a   Meloni, B P ^a,b   Mastaglia, F L ^a   Greene, W K ^c   Boulos, S ^a  

^a UNIVERSITY OF WESTERN AUSTRALIA   (Australia)

^b SIR CHARLES GAIRDNER HOSPITAL   (Australia)

^c MURDOCH UNIVERSITY   (Australia)

Author keywords

Adenoviral; Anti apoptotic; Caspase 3; SMA; SMN

Indexed keywords

ADENOVIRUS VECTOR; CASPASE 3; PHOSPHATIDYLINOSITOL 3 KINASE; PROCASPASE 3; PROTEIN KINASE B; SURVIVAL MOTOR NEURON PROTEIN;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL DEATH; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME INHIBITION; EXCITOTOXICITY; HUMAN; HUMAN CELL; NEUROPROTECTION; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN CLEAVAGE; PROTEIN EXPRESSION; RAT;

ANIMALS; APOPTOSIS; CALPAIN; CASPASE 3; CELL LINE; CELL LINE, TUMOR; CELL SURVIVAL; CELLS, CULTURED; ENZYME ACTIVATION; GENE EXPRESSION REGULATION, ENZYMOLOGIC; HUMANS; NEURONS; RATS; SURVIVAL OF MOTOR NEURON 1 PROTEIN;

EID: 79953718027     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2011.02.032     Document Type: Article

References (48)

1. Benn S.C., Perrelet D., Kato A.C., Scholz J., Decosterd I., Mannion R.J., Bakowska J.C., Woolf C.J. Hsp27 upregulation and phosphorylation is required for injured sensory and motor neuron survival. Neuron 2002, 36:45-56.
2. Bissonnette C.J., Klegeris A., McGeer P.L., McGeer E.G. Interleukin 1α and interleukin 6 protect human neuronal SH-SY5Y cells from oxidative damage. Neurosci Lett 2004, 361(1-3):40-43.
3. Boulos S., Meloni B., Arthur P., Bojarski C., Knuckey N. Assessment of CMV, RSV and SYN1 promoters and the woodchuck post-transcriptional regulatory element in adenovirus vectors for transgene expression in cortical neuronal cultures. Brain Res 2006, 1102(1):27-38.
4. Cisterni C., Kallenbach S., Jordier F., Bagnis C., Pettmann B. Death of motoneurons induced by trophic deprivation or by excitotoxicity is not prevented by overexpression of SMN. Neurobiol Dis 2001, 8(2):240-251.
5. Concannon C.G., Gorman A.M., Samali A. On the role of Hsp27 in regulating apoptosis. Apoptosis 2003, 8(1):61-69.
6. Coovert D., Le T., McAndrew P., Strasswimmer J., Crawford T., Mendell J., Coulson S., Androphy E., Prior T., Burghes A. The survival motor neuron protein in spinal muscular atrophy. Hum Mol Genet 1997, 6(8):1205-1214.
7. Crawford T.O., Pardo C.A. The neurobiology of childhood spinal muscular atrophy. Neurobiol Dis 1996, 3:97-110.
8. Deveraux Q.L., Roy N., Stennicke H.R., Van Arsdale T., Zhou Q., Srinivasula S.M., Alnemri E.S., Salvesen G.S., Reed J.C. IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. Eur Mol Biol Organ 1998, 17:2215-2223.
9. Dietz G.P., Dietz B., Bahr M. Bcl-xL protects cerebellar granule neurons against the late phase, but not against the early phase of glutamate-induced cell death. Brain Res 2007, 1164:136-141.
10. Encinas M., Iglesias M., Liu Y., Wang H., Muhaisen A., Cena V., Gallego C., Comella J. Sequential treatment of SH-SY5Y cells with retinoic acid and brain-derived neurotrophic factor gives rise to fully differentiated, neurotrophic factor-dependent, human neuron-like cells. J Neurochem 2000, 75:991-1003.
11. Feldkotter M., Schwarzer V., Wirth R., Wienker T.F., Wirth B. Quantitative analyses of SMN1 and SMN2 based on real-time lightCycler PCR: fast and highly reliable carrier testing and prediction of severity of spinal muscular atrophy. Am J Hum Genet 2002, 70:358-368.
12. Fujiwara Y., Kawada K., Takano D., Tanimura S., Ozaki K., Kohno M. Inhibition of the PI3 kinase/Akt pathway enhances doxorubicin-induced apoptotic cell death in tumor cells in a p53-dependent manner. Biochem Biophys Res Commun 2006, 340(2):560-566.
13. Gangwani L., Mikrut M., Theroux S., Sharma M., Davis R.J. Spinal muscular atrophy disrupts the interaction of ZPR1 with the SMN protein. Nat Cell Biol 2001, 3(4):376-383.
14. Han Z., Hendrickson E.A., Bremner T.A., Wyche J.H. A sequential two-step mechanism for the production of the mature p17:p12 form of caspase-3 in vitro. J Biol Chem 1997, 272(20):13432-13436.
15. He T.C., Zhou S., Da Costa L.T., Yu J., Kinzler K.W., Vogelstein B. A simplified system for generating recombinant adenoviruses. Proc Natl Acad Sci U S A 1998, 95:2509-2514.
16. Jamsa A., Hasslund K., Cowburn R., Backstrom A., Vasange M. The retinoic acid and brain-derived neurotrophic factor differentiated SH-SY5Y cell line as a model for Alzheimer's disease-like tau phosphorylation. Biochem Biophys Res Commun 2004, 319:993-1000.
17. Kerr D.A., Nery J.P., Traystman R.J., Chau B.N., Hardwick J.M. Survival motor neuron protein modulates neuron-specific apoptosis. Proc Natl Acad Sci USA 2000, 97(24):13312-13317.
18. Lefebvre S., Bürglen L., Frézal J., Munnich A., Melki J. The role of the SMN gene in proximal spinal muscular atrophy. Hum Mol Genet 1998, 7(10):1531-1536.
19. Lefebvre S., Bürglen L., Reboullet S., Clermont O., Burlet P., Viollet L., Benichou B., Cruaud C., Millasseau P., Zeviani M., et al. Identification and characterization of a spinal muscular atrophy-determining gene. Cell 1995, 80(1):155-165.
20. Lefebvre S., Burlet P., Liu Q., Bertrandy S., Clermont O., Munnich A., Dreyfuss G., Melki J. Correlation between severity and SMN protein level in spinal muscular atrophy. Nat Genet 1997, 16:265-269.
21. Liu Q., Dreyfuss G. A novel nuclear structure containing the survival of motor neurons protein. EMBO J 1996, 15(14):3555-3565.
22. Lorson C.L., Androphy E.J. An exonic enhancer is required for inclusion of an essential exon in the SMA-determining gene SMN. Hum Mol Genet 2000, 9:259-265.
23. McAndrew P.E., Parsons D.W., Simard L.R., Rochette C., Ray P.N., Mendell J.R., Prior T.W., Burghes A.H. Identification of proximal spinal muscular atrophy carriers and patients by analysis of SMNT and SMNC gene copy number. Am J Hum Genet 1997, 60(6):1411-1422.
24. McGinnis K.M., Gnegy M.E., Park Y.H., Mukerjee N., Wang K.K. Procaspase-3 and poly(ADP)ribose polymerase (PARP) are calpain substrates. Biochem Biophys Res Commun 1999, 263(1):94-99.
25. Meade A.J., Meloni B.P., Cross J., Bakker A.J., Fear M.W., Mastaglia F.L., Watt P.M., Knuckey N.W. AP-1 inhibitory peptides are neuroprotective following acute glutamate excitotoxicity in primary cortical neuronal cultures. J Neurochem 2010, 112(1):258-270.
26. Meergans T., Hildebrandt A.K., Horak D., Haenisch C., Wendel A. The short prodomain influences caspase-3 activation in HeLa cells. Biochem J 2000, 349(1):135-140.
27. Meloni B.P., Madja B.T., Knuckey N.W. Establishment of neuronal in vitro models of ischemia in 96-well microtiter strip-plates that result in acute, progressive and delayed neuronal death. Neuroscience 2001, 108(1):17-26.
28. Pandey P., Farber R., Nakazawa A., Kumar S., Bharti A., Nalin C., Weichselbaum R., Kufe D., Kharbanda S. Hsp27 functions as a negative regulator of cytochrome c-dependent activation of procaspase-3. Oncogene 2000, 19:1975-1981.
29. Panickar K.S., Nonner D., Barrett J.N. Overexpression of Bcl-xl protects septal neurons from prolonged hypoglycemia and from acute ischemia-like stress. Neuroscience 2005, 135(1):73-80.
30. Parker G., Li X., Anguelov R., Toth G., Cristescu A., Acsadi G. Survival motor neuron protein regulates apoptosis in an in vitro model of spinal muscular atrophy. Neurotox Res 2008, 13(1):39-48.
31. Reilly M.M., Shy M.E. Diagnosis and new treatments in genetic neuropathies. J Neurol Neurosurg Psychiatry 2009, 80:1304-1314.
32. Roberts D.F., Chavez J., Court S.D.M. The genetic component in child mortality. Arch Dis Child 1970, 45:33-38.
33. Rochette C., Gilbert N., Simard L. SMN gene duplication and the emergence of the SMN2 gene occurred in distinct hominids: SMN2 is unique to Homo sapiens. Hum Genet 2001, 108:255-256.
34. Rossoll W., Jablonka S., Andreassi C., Kröning A., Karle K., Monani U.R., Sendtner M. Smn, the spinal muscular atrophy-determining gene product, modulates axon growth and localization of β-actin mRNA in growth cones of motoneurons. J Cell Biol 2003, 163(4):801-812.
35. Simic G., Mladinov M., Seso Simic D., Jovanov Milosevic N., Islam A., Pajtak A., Barisic N., Sertic J., Lucassen P.J., Hof P.R., Kruslin B. Abnormal motoneuron migration, differentiation, and axon outgrowth in spinal muscular atrophy. Acta Neuropathol 2008, 115(3):313-326.
36. Simic G., Seso-Simic D., Lucassen P.J., Islam A., Krsnik Z., Cviko A., Jelasic D., Barisic N., Winblad B., Kostovic I., Kruslin B. Ultrastructural analysis and TUNEL demonstrate motor neuron apoptosis in Werdnig-Hoffmann disease. J Neuropathol Exp Neurol 2000, 59(5):398-407.
37. Skulachev V.P. Bioenergetic aspects of apoptosis, necrosis and mitoptosis. Apoptosis 2006, 11(4):473-485.
38. Soler-Botija C., Ferrer I., Alvarez J.L., Baiget M., Tizzano E.F. Downregulation of Bcl-2 proteins in type I spinal muscular atrophy motor neurons during fetal development. J Neuropathol Exp Neurol 2003, 62(4):420-426.
39. Tsai M.S., Chiu Y.T., Wang S.H., Hsieh-Li H.M., Lian W.C., Li H. Abolishing Bax-dependent apoptosis shows beneficial effects on spinal muscular atrophy model mice. Mol Ther 2006, 13(6):1149-1155.
40. Tsai L.K., Tsai M.S., Ting C.H., Wang S.H., Li H. Restoring Bcl-x(L) levels benefits a mouse model of spinal muscular atrophy. Neurobiol Dis 2008, 31(3):361-367.
41. Tsujimoto Y., Shimizu S., Eguchi Y., Kamiike W., Matsuda H. Bcl-2 and Bcl-xL block apoptosis as well as necrosis: possible involvement of common mediators in apoptotic and necrotic signal transduction pathways. Leukemia 1997, 3:380-382.
42. van Bergeijk J., Rydel-Konecke K., Grothe C., Claus P. The spinal muscular atrophy gene product regulates neurite outgrowth: importance of the C terminus. FASEB J 2007, 21(7):1492-1502.
43. Vyas S., Béchade C., Riveau B., Downward J., Triller A. Involvement of survival motor neuron (SMN) protein in cell death. Hum Mol Genet 2002, 11(22):2751-2764.
44. Walker M.P., Rajendra T.K., Saieva L., Fuentes J.L., Pellizzoni L., Matera A.G. SMN complex localizes to the sarcomeric Z-disc and is a proteolytic target of calpain. Hum Mol Genet 2008, 17(21):3399-3410.
45. Wang W., DiMatteo D., Funanage V., Scavina M. Increased susceptibility of spinal muscular atrophy fibroblasts to camptothecin-induced cell death. Mol Genet Metab 2005, 85:38-45.
46. Wolf B.B., Goldstein J.C., Stennicke H.R., Beere H., Amarante-Mendes G.P., Salvesen G.S., Green D.R. Calpain functions in a caspase-independent manner to promote apoptosis-like events during platelet activation. Blood 1999, 94(5):1683-1692.
47. Xu L., Koumenis I.L., Tilly J.L., Giffard R.G. Overexpression of bcl-xL protects astrocytes from glucose deprivation and is associated with higher glutathione, ferritin, and iron levels. Anesthesiology 1999, 91(4):1036-1046.
48. Zeng M., Smith S.K., Siegel F., Shi Z., Van Kampen K.R., Elmets C.A., Tang D.C. AdEasy system made easier by selecting the viral backbone plasmid preceding homologous recombination. Biotechniques 2001, 31(2):260-262.